IO Biotech Stock (NASDAQ: IOBT) stock price, news, charts, stock research, profile.
Open | $1.430 |
Close | $1.420 |
Volume / Avg. | 73.378K / 134.865K |
Day Range | 1.400 - 1.540 |
52 Wk Range | 0.816 - 2.640 |
Market Cap | $94.869M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 35 |
Short Interest | 0.13% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of IO Biotech (NASDAQ: IOBT) through any online brokerage.
Other companies in IO Biotech’s space includes: Anixa Biosciences (NASDAQ:ANIX), CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB), Burning Rock Biotech (NASDAQ:BNR) and FibroGen (NASDAQ:FGEN).
The latest price target for IO Biotech (NASDAQ: IOBT) was reported by HC Wainwright & Co. on Wednesday, March 6, 2024. The analyst firm set a price target for 8.00 expecting IOBT to rise to within 12 months (a possible 455.56% upside). 5 analyst firms have reported ratings in the last year.
The stock price for IO Biotech (NASDAQ: IOBT) is $1.44 last updated April 25, 2024 at 4:38 PM EDT.
There are no upcoming dividends for IO Biotech.
IO Biotech’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for IO Biotech.
IO Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.